ClinicalTrials.Veeva

Menu

AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction

A

AggreDyne

Status

Completed

Conditions

Platelet Dysfunction Due to Aspirin Ingestion

Study type

Observational

Funder types

Industry

Identifiers

NCT01915407
AGD 051

Details and patient eligibility

About

To test the AggreGuide A-100 AA Assay's effectiveness for detecting aspirin induced platelet dysfunction.

Enrollment

150 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • over 18

Exclusion criteria

  • on aspirin in prior week
  • medical history of platelet disorders
  • contraindications to aspirin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems